- In July 2023, Almac Group opened a custom-built GMP warehouse and dispatch hub in the UK. The facility aimed to support all the manufacturing and laboratory activities of API from drug development to commercialization. Such expansion strengthened broadened company’s offerings in the market.
- In February 2023, Catalent completed a USD 2.2 million expansion of its clinical supply facility in Singapore. This expansion has enlarged the site's footprint to 31,000 square feet, providing room for installing 35 new freezers dedicated to ultra-low temperature (ULT) storage, thereby strengthening the company’s operational capabilities in the supply chain management.
- In January 2023, ASLAN Pharmaceuticals partnered with Thermo Fisher Scientific to manufacture a high-concentration formulation of Eblasakimab for forthcoming studies. Through this partnership, Thermo Fisher Scientific contributes its expertise in biologic manufacturing and scale-up capacity to manage a clinical supply of Eblasakimab for the anticipated Phase 3 studies
- In July 2023, Almac Sciences unveiled a custom-built GMP warehouse and dispatch hub at the Almac Group's global headquarters in Craigavon, UK. This new facility is designed to support the entire manufacturing and laboratory activities related to Active Pharmaceutical Ingredients, from development through to commercialization
- In February 2023, Catalent announced the completion of a $2.2 million expansion of its clinical supply facility in Singapore. This enhancement increased the facility's footprint to 31,000 square feet, allowing for the installation of 35 new freezers specifically designed for ultra-low temperature (ULT) storage. This strategic expansion not only boosts capacity but also strengthens Catalent's ability to meet the growing demand for clinical trial materials requiring precise storage conditions
